Publications

Our scientific publications in high-quality journals reflect the quality of the innovative research in Entasis’ laboratories.

Search by Program

Olivier NB, Altman RB, Noeske J, Basarab G, Code E, Ferguson AD, Gao N, Huang J, Juette M, Livchak S, Miller MD, Prince DB, Cate JHD, Buurman ET, Blanchard

Negamycin induces translational stalling and miscoding by binding to the small subunit head domain of the Escherichia coli ribosome

PNAS (2014)

Brown DG, May-Dracka TL, Gagnon MM, Tommasi R

Trends and Exceptions of Physical Properties on Antibacterial Activity for Gram-Positive and Gram-Negative Pathogens

Journal of Medicinal Chemistry (2014)

Basarab GS, Brassil P, Doig P, Galullo V, Haimes HB, Kern G, Kutschke A, McNulty J, Schuck VJ, Stone G, Gowravaram M

Novel DNA Gyrase Inhibiting Spiropyrimidinetriones with a Benzisoxazole Scaffold: SAR and in Vivo Characterization

Journal of Medicinal Chemistry (2014)

Ehmann DE, Jahic H, Ross PL, Gu RF, Hu J, Durand-Réville TF, Lahiri S, Thresher J, Livchak S, Gao N, Palmer T, Walkup GK, Fisher SL

Kinetics of avibactam inhibition against class A, C, and D β-lactamases

Journal of Biological Chemistry (2013)

Keirstead ND, Wagoner MP, Bentley P, Blais M, Brown C, Cheatham L, Ciaccio P, Dragan Y, Ferguson D, Fikes J, Galvin M, Gupta A, Hale M, Johnson N, Luo W, McGrath F, Pietras M, Price S, Sathe AG, Sasaki JC, Snow D, Walsky RL, Kern G

Early prediction of polymyxin-induced nephrotoxicity with next generation urinary kidney injury biomarkers

Toxicological Sciences (2013)

Ehmann DE, Jahic H, Ross PL, Gu RF, Hu J, Kern G, Walkup GK, Fisher S

Avibactam is a covalent, reversible, non-β-lactam β-lactamase inhibitor.

Proceedings of the National Academy of Sciences of the United States of America (2012)